Should angiotensin-converting enzyme inhibitors be continued over the long term in patients whose left ventricular ejection fraction normalizes after an episode of acute myocarditis?;¿Se deben mantener los inhibidores de la enzima de conversión de la angiotensina a largo plazo en pacientes que normalizan la fracción de eyección tras un episodio de miocarditis aguda?

Revista Espanola de Cardiologia

Volumn 59, Issue 11, 2006, Pages 1199-1201

  Anguita Sánchez, Manuel ^a,b   Castillo Domínguez, Juan C ^a   Mesa Rubio, Dolores ^a   Ruiz Ortiz, Martín ^a   López Granados, Amador ^a   de Lezo, José Suárez ^a  

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^b NONE   (Spain)

Author keywords

ACE inhibitors; Acute myocarditis; Prognosis

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; INCIDENCE; LONG TERM CARE; MALE; MORTALITY; MYOCARDITIS; PROGNOSIS; SCHOOL CHILD; SYSTOLIC DYSFUNCTION; TREATMENT RESPONSE; ACUTE DISEASE; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; PHYSIOLOGY; TIME;

ACUTE DISEASE; ADULT; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MYOCARDITIS; STROKE VOLUME; TIME FACTORS; VENTRICULAR FUNCTION, LEFT;

EID: 33846407297     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1157/13095790     Document Type: Article

References (6)

1. Grupo de Trabajo de diagnóstico y tratamiento de la insuficiencia cardiaca crónica de la Sociedad Europea de Cardiología. Guías de práctica clínica sobre el diagnóstico y tratamiento de la insuficiencia cardiaca crónica (versión resumida, actualización 2005). Rev Esp Cardiol. 2005;58:1062-92.
2. Torres F, Anguita M, Jiménez D, Mesa D, Tejero I, Franco M, et al. Evolución a largo plazo de la miocarditis aguda. Estudio prospectivo de una serie de 99 pacientes (1987-1995). Rev Esp Cardiol. 1996;49:723-31.
3. Felker GM, Thompson RE, Hare JM, Hruban RH, Clemetson DE, Howard DL, et al. Underlying causes and long term survival in patients with initially unexplained cardiomyopathy. N Engl J Med. 2000;342:1077-84.
4. Godsel LM, León JS, Engman D. Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists in experimental myocarditis. Curr Pharm Des. 2003;9:723-35.
5. Nakazawa JW, Watanabe K, Ma M, Wahed MI, Hasegawa G, Natio M, et al. Quinapril inhibits progression of heart failure and fibrosis in rats with dilated cardiomyopathy after myocarditis. Mol Cell Biochem. 2003;251:77-82.
6. Rezkalla S, Kloner RA, Khatib G, Khatig R. beneficial effects of captopril in acute coxsackievirus B3 murine myocarditis. Circulation. 1990;81:1039-46.